|
| |
| | | 68947 | | 14.09.2023 | | AbbVie AG | | | | | | | 13.09.2028 | | | | | | 07.15. | | | | 07.15. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Skyrizi 600 mg/10 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Risankizumabum 600mg / 10ml) | L04AC18 | |
|
|
|
